Top News
Latest News
INVESTMENT
12 Jan 2026
Lilly’s Ventyx Deal Points to a Future Beyond InjectionsMARKET TRENDS
8 Jan 2026
Oral Weight Loss Pills Are Shaking Up Metabolic CarePARTNERSHIPS
6 Jan 2026
Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms RaceRESEARCH
19 Dec 2025
Liver-First Drugs Redefine the Next Phase of the MASH Race
FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs
REGULATORY
18 Dec 2025
A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the sector
PARTNERSHIPS
26 Jul 2025
One Shot for Cholesterol? Lilly Thinks the Future Is Here
Lilly's Verve buyout could turn lifelong cholesterol drugs into a one-time genetic fix.
INNOVATION
28 Jun 2025
CRISPR’s Bold Bet: One Shot to Disrupt Cholesterol Care
CTX310 shows up to 86% LDL reduction in early trial, with full results expected in 2025
INNOVATION
25 Jun 2025
From Needle to Pill: The New Face of Obesity Treatment
Novo's amycretin pill shows big early weight-loss results, hinting at a future beyond injections.
RESEARCH
21 Jun 2025
Stem Cell Trial Offers Hope for Insulin-Free Diabetes
Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.